Konsume
Interval Day Week Month
Range 30 Day 90 Day 6 Months 1 Yr
Newswire Search Past 90 Days 3 stories 1 Publishers
Trending Today
Sort By: Snapshot
Buzz
Media Coverage
World View
Related Topics
Topic # Mentions Topic Reach
phase3-
sac3-
esmo3-
thailand3-
thailand business news3-
business3-
business news3-
news3-
Prominent Journalists
Byline Articles Written Avg Reach
by PR Newswire 3 -


Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO – Thailand Business News
by PR Newswire — thailand-business-news.com


The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine – Thailand Business News
by PR Newswire — thailand-business-news.com


Phase II Results of Sacituzumab Tirumotecan (sac-TMT) plus Pembrolizumab in Advanced Urothelial Carcinoma Presented at 2026 ESMO – Thailand Business News
by PR Newswire — thailand-business-news.com

Execution: 2.21 Seconds. 31.82 mb used.